Blog

Home  /  News   /  Roche Pharma reviews the HTA Core Model® from a pharmaceutical perspective

Roche Pharma reviews the HTA Core Model® from a pharmaceutical perspective

In a report published in December 2014, Roche Pharma reviews the usefulness of the EUnetHTA Core model® for Roche’s internal HTA assembling, storing and sharing purposes.

In a report published in December 2014, Roche Pharma reviews the usefulness of the EUnetHTA Core model® for Roche’s internal HTA assembling, storing and sharing purposes.

The report focuses on the Pharmaceutical application of the HTA Core Model® and the value assessment of Pharmaceuticals.

Find the report and its appendices attached below.
appendix_5_unimportant_elements_3_5_wo_canada1

roche_pharma_report_on_the_hta_core_model_december2014_0
appendix_6_important_vers2_value_proposition_not_payers_wo_canada_korr6

appendix_2_unimportant_detail

appendix_3_oct_overall_important_elements_4_5_transferable_elements_4_5wo_canada1
appendix_4_important_elements_4_5_wo_canada